x
Filter:
Filters applied
- ACMG Statements and Guidelines
- Gregg, Anthony RRemove Gregg, Anthony R filter
- Bajaj, KRemove Bajaj, K filter
- prenatal genetic screeningRemove prenatal genetic screening filter
ACMG Statements and Guidelines
These online statements and guidelines are definitive and may be cited using the digital object identifier (DOI). These recommendations are designed primarily as an educational resource for medical geneticists and other healthcare providers to help them provide quality medical genetics services; they should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed to obtaining the same results. Please refer to the leading disclaimer in each document for more information.
1 Results
- ACMG Policy StatementOpen Access
ACMG statement on noninvasive prenatal screening for fetal aneuploidy
Genetics in MedicineVol. 15Issue 5p395–398Published in issue: May, 2013- Anthony R. Gregg
- S.J. Gross
- R.G. Best
- K.G. Monaghan
- K. Bajaj
- B.G. Skotko
- and others
Cited in Scopus: 230Noninvasive assessment of the fetal genome is now possible using next-generation sequencing technologies. The isolation of fetal DNA fragments from maternal circulation in sufficient quantity and sizes, together with proprietary bioinformatics tools, now allows patients the option of noninvasive fetal aneuploidy screening. However, obstetric care providers must become familiar with the advantages and disadvantages of the utilization of this approach as analysis of cell-free fetal DNA moves into clinical practice.
